CSL trades at a discount despite owning a dominant, hard-to-replicate global plasma-derived therapies infrastructure. Transformation Program targets $500–$550M in annual pre-tax cost reductions by ...
Want a feel-good side gig that requires no work, no skill and no experience? Consider plasma donation through CSL Plasma. It’s a lot like giving blood, but you get paid — sometimes generously. CSL ...
We transfer coverage of CSL, a global leader in plasma therapies, influenza vaccinations, and iron and kidney products. Shares have plummeted over 60% in the last two years on several earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results